Cross-reactivity of anti-phosphorylcholine antibodies to neuromuscular blockers in a murine model of immunization

International Immunopharmacology

Volumn 7, Issue 9, 2007, Pages 1170-1178

  Mazzuco, Rosa Maria ^a   Sato, Maria Notomi ^a   Vasconcelos, Dewton de Moraes ^a   Duarte, Alberto José da Silva ^a  

^a LIM 56   (Brazil)

Author keywords

Cross reactivity; Mice; Neuromuscular blocking agents; Phosphorylcholine; Sex

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; NEUROMUSCULAR BLOCKING AGENT; NITROPHENYLPHOSPHORYLCHOLINE; PHOSPHORYLCHOLINE; PHOSPHORYLCHOLINE ANTIBODY; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EXPOSURE; EPITOPE MAPPING; FEMALE; HYPERSENSITIVITY REACTION; IMMUNIZATION; MALE; MOUSE; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES; FEMALE; HEMOCYANIN; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; NEUROMUSCULAR BLOCKING AGENTS; PHOSPHORYLCHOLINE; RATS; RATS, INBRED LEW;

EID: 34447271749     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.04.011     Document Type: Article

References (43)

1. Fisher M.M. The diagnosis of acute anaphylactoid reaction to anaesthetic drugs. Anaesth Intensive Care 9 (1981) 235-241
2. Gallently D.C., and Treuren B.C. Anaphylactoid reaction during anaesthesia. Anaesthesia 40 (1985) 329-333
3. Mertes P.-M., and Lavenaire M.C. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 4 (2004) 7-17
4. Laxenaire M.C. Epidémiologie des reactions anaphylactoides peranesthésiques. Quatrième enquête multicentrique (luillet 1994-décembre 1996). Ann Fr Anesth Reanim 18 (1999) 796-809
5. Harle D.G., Baldo B.A., and Fisher M.M. Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia. Lancet 1 (1984) 930-932
6. Dybendal T., Guttormsen A.B., Elsayed S., Askeland B., Harboe T., and Florvaag E. Screening for mast cell trypase and serum IgE antibodies against ammonium groups, choline, morphine, suxamethonium, thiopentone and latex in follow-up of 18 patients after anaphylactic reactions during general anaesthesia. Acta Anaesthesiol Scand 47 (2003) 1211-1218
7. Moneret-Vautrin D.A., Laxenaire M.C., Hummer-Siegel M., Mouton C., and Guéant J.L. Myorelaxants. In: Laxenaire M.C., and Moneret-Vautrin D.A. (Eds). Le risque allergique en anesthésie - réanimation (1990), Masson, Paris 72-81
8. Vuitton D., Laurent R., and Baralle F. Charactéristiques épidemiologiques de 21 accidents anaphylactoïdes peranesthésiques observés dans une population de 12 855 sujets opérés. Ann Fr Anesth Réanim 4 (1985) 167-172
9. Youngman P.R., Taylor K.M., and Wilson J.D. Anaphylactoid reactions to neuromuscular blocking agents: a common undiagnosed condition?. Lancet 2 (1983) 597-598
10. Baldo B.A., and Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306 (1983) 262-264
11. Harle D.G., Baldo B.A., and Fisher M.M. Assays for and cross-reactivities of IgE antibodies to the muscle relaxants gallamine, decamethonium and succinylcholine (suxamethonium). J Immunol Methods 78 (1985) 293-305
12. Fisher M.M., and Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 28 (2000) 167-170
13. Didier A., Benzarti M., Senft M., Charpin D., Lagier F., Charpin J., et al. Allergy to suxamethonium: persisting abnormalities in skin tests, specific IgE antibodies and leukocyte histamine release. Clin Allergy 17 (1987) 385-392
14. Porri F., Lemiere C., Birnbaum J., Guilloux L., Lanteaume A., Didelot R., et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 29 (1999) 72-75
15. Harle D.G., Baldo B.A., and Fisher M.M. Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anesth 57 (1985) 1073-1076
16. Moneret-Vautrin D.A., Widmer S., and Mata A. Détéction d'une sensibilisation latent aux myorelaxants par prick-tests. Ann Fr Anesth Réanim 8 (1989) 293-294
17. Assem E.S.K., and Ezeamuzie I.C. Suxamethonium-induced histamine release from the heart of naïve and suxamethonium-sensitized guinea-pigs: evidence suggesting spontaneous sensitization in naïve animals, and relevance to anaphylactoid reactions in man. Agents and Actions 27 (1989) 146-149
18. Chesebro B., and Metzger H. Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry 11 (1972) 766-771
19. Mota I., and Wong D. Homologous passive cutaneous anaphylaxis in the mouse. Life Sci 8 (1969) 813-820
20. Perlmutter R.M., Crews S.T., Douglas R., Sorensen G., Johnson N., Nivera N., et al. The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol 35 (1984) 1-37
21. Schreiber J., Laurence J., Cooper N., Scott D., Dahlhauser P.A., Tosi F., et al. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lypopolysaccharide O-specific side chain function differently. J Infect Dis 167 (1993) 221-226
22. Scott M.G., Briles D.E., Shackelford P.G., Smith D.S., and Nahm M.H. Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J Immunol 138 (1987) 3325-3331
23. Claflin J.L., and Davies J.M. Clonal nature of the immune response to phosphorylcholine: III. Species-specific binding characteristics of rodent anti-phosphorylcholine antibodies. J Immunol 113 (1974) 1678-1688
24. Almond N.M., and Parkhouse M.E. The Ig class distribution of anti-phosphorylcholine responses in mice infected with parasitic nematodes. Immunology 59 (1986) 633-635
25. Gillespie S.H., Ainscough S., Dickens A., and Lewin J. Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract. J Med Microbiol 44 (1996) 35-40
26. Fisher R.T., Longo D.L., and Kenny J. A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. J Immunol 154 (1995) 3373-3382
27. Seoane R., Eiras A., Quireza O., Cancio E., Aguilera A., and Puentes E. Interference between Neisseria meningitidis and PC-KLH induced anti-phosphocholine PFC responses in NZB/W autoimmune mice. Microbiol Immunol 39 (1995) 491-497
28. Gibb D., Spölou V., Giacomelli A., Griffiths H., Masters J., Misbah S., et al. Antibody response to Haemophylus influenzae type B and Streptoccocus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediat Inf Dis J 14 (1995) 129-135
29. Kantor A.B., Merrill C.E., Herzenberg L.A., and Hillson J.L. An unbiased analysis of V(H)-d-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 158 (1997) 1175-1186
30. Shaw P.X., Hörkkö S., Chang M.-K., Curtiss L.K., Palinski W., Silverman G.J., and Witztum J.L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105 (2000) 1731-1740
31. Briles D.E., Forman C., Hudak S., and Claflin J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156 (1982) 1177-1185
32. Strait R.T., Morris S.C., and Finkelman F.D. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking. J Clin Invest 116 (2006) 833-841
33. Finkelman F.D., Rothenberg M.E., Brandt E.B., Morris S.C., and Strait R.T. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 115 (2005) 449-457
34. Sato M.N., Oliveira C.R., Futata E.A., Victor J.R., Maciel M., Fusaro A.E., et al. Oral tolerance induction to Dermatophagoides pteronyssinus and Blomia tropicalis in sensitized mice: occurrence of natural autoantibodies to IgE. Clin Exp Allergy 32 (2002) 1667-1674
35. Victor J.R., Fusaro A.E., Duarte A.J.S., and Sato M.N. Preconception maternal immunization to dust mite inhibits type I hypersensitivity response of offspring by modulating B and T responses. J Allergy Clin Immunol 111 (2003) 269-277
36. Guilloux L., Ricard-Blum S., Ville G., and Motin J. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 90 (1992) 153-159
37. Weber E.A., Heusser C.H., and Blaser K. Fine specificity and idiotype expression of anti-phosphorylcholine IgE and IgG antibodies. Eur J Immunol 16 (1986) 919-923
38. Lötscher M., Blaser K., and Heusser C.H. Specific V gene usage in anti-phosphorylcholine IgE antibodies. Mol Immunol 30 (1993) 1573-1582
39. Tamayo E., Álvarez F.J., Rodrigues-Ceron G., Gómez-Herreras J.I., and Castrodeza J. Prevalence of positive prick test to anaesthetic drugs in the surgical population. Allergy 61 (2006) 952-953
40. Kraft D., Hedin H., Richter W., Scheiner O., Rumpold H., and Devey M.E. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non reactors to clinical dextran. Allergy 37 (1982) 481-489
41. Deenick E.K., Hasbold J., and Hodgkin P.D. Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J Immunol 163 (1999) 4707-4714
42. Baldo B.A., and Fisher M.M. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 201 (1983) 393-400
43. Galli S.J. Pathogenesis and management of anaphylaxis: current status and future challenges. J Allergy Clin Immunol 115 (2005) 571-574